A consortium of the UK's largest and most successful scientific and academic institutions has laid out its plans for the biggest centre for biomedical research and innovation in Europe. The UK Centre ...

British biotech IPOs in 2022 dropped to their lowest levels in a decade, with the amount the sector raised also plummeting year over year. However, some hope may be on the horizon in the form of ...

Josh is the Global Real Estate transaction lead for GSK, focusing on aligning real estate strategies with business objectives and transforming the portfolio to create the World’s healthiest workplaces ...

Allison DeAngelis is the East Coast biotech and venture capital reporter at STAT, reporting where scientific ideas and money meet. She is also co-host of the weekly biotech podcast, The Readout Loud.

Allison DeAngelis is the East Coast biotech and venture capital reporter at STAT, reporting where scientific ideas and money meet. She is also co-host of the weekly biotech podcast, The Readout Loud.

Eli Lilly & Co plans to invest £279 million ($364 million) in a new initiative to support UK biotechs along with a study of the impact of its blockbuster drugs for diabetes and obesity on the use of ...

Hoxton Farms, a London-based biotech startup, has opened today the UK’s first pilot production facility for cultivated animal fat. Launched in 2020, the company combines cell biology and mathematical ...

LONDON, March 13 (Reuters) - HSBC (HSBA.L), opens new tab's rescue of the British arm of Silicon Valley Bank saved the heavily-exposed UK biotech sector from collapse, but the fallout could hamper ...

GLASGOW, Scotland--(BUSINESS WIRE)--UK-based biotechnology company ILC Therapeutics (ILCT) today announced that it has secured significant investment from its first global investor Medical Incubator ...

Further expansion of Bayer’s drug development pipeline in Women’s Healthcare Phase IIb dose range finding study results recently published for the investigational non-hormonal oral compound NT-814 to ...